VIR-3434 clinical trials

SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.

This study looks at new drug combinations (VIR-2218 and VIR-3434) to treat long-lasting Hepatitis D infection. It's a Phase 2 trial, meaning researchers are checking if these treatments are safe, handleable, and work well in people.